INTECH Investment Management’s Altimmune ALT Stock Holding History

INTECH Investment Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$140K	Buy	45,911 +15,150	+49%	+$45.3K	﹤0.01%	1878
2026 Q1	$94.7K	Sell	30,761 -21,796	-41%	-$92.5K	﹤0.01%	1903
2025 Q4	$190K	Buy	52,557 +13,918	+36%	+$60.7K	﹤0.01%	2007
2025 Q3	$146K	Sell	38,639 -106,251	-73%	-$410K	﹤0.01%	2162
2025 Q2	$561K	Buy	144,890 +73,482	+103%	+$398K	0.01%	1540
2025 Q1	$357K	Buy	71,408 +25,285	+55%	+$160K	﹤0.01%	1794
2024 Q4	$333K	Buy	46,123 +12,385	+37%	+$94.6K	﹤0.01%	1782
2024 Q3	$207K	Buy	+33,738	New	+$229K	﹤0.01%	1700

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's ALT Position: Q2 2026 in Review

INTECH Investment Management increased its Altimmune (ALT) stake by 49% in Q2 2026, buying an estimated $45.3K and bringing the position to 45,911 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

INTECH Investment Management first reported a position in ALT in Q3 2024 and has held it in 8 quarters since. The position peaked at $561K in Q2 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

INTECH Investment Management held 45,911 shares of Altimmune worth $140K as of Q2 2026.
INTECH Investment Management bought 15,150 Altimmune shares in Q2 2026, an estimated $45.3K.
Altimmune made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1878 holding.
INTECH Investment Management first reported a position in Altimmune in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Altimmune position peaked at $561K in Q2 2025.
210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.